Dr. Lal PathLabs Ltd
BSE: 539524
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 832.10+8.9% | 764.40+13.2% | 675.20+6.8% | 632.10-9.6% | 699.60+9.2% | 640.70+11.0% | 577.20+9.3% | 528.10 |
| Other Income | 33.90+13.4% | 29.90-19.2% | 37.00+39.1% | 26.60+16.7% | 22.80-13.3% | 26.30+4.4% | 25.20-14.6% | 29.50 |
| Total Income | 866.00+9.0% | 794.30+11.5% | 712.20+8.1% | 658.70-8.8% | 722.40+8.3% | 667.00+10.7% | 602.40+8.0% | 557.60 |
| EXPENSES | ||||||||
| Expenditure | 625.10+9.3% | 572.00+5.5% | 542.30+7.3% | 505.50-4.2% | 527.60+6.7% | 494.60+8.1% | 457.50+12.6% | 406.40 |
| Tax | 61.20+8.5% | 56.40+95.8% | 28.80-7.1% | 31.00-36.9% | 49.10+13.9% | 43.10+1331.4% | -3.50-109.5% | 36.70 |
| PROFIT | ||||||||
| PBT | 240.90+8.4% | 222.30+30.8% | 169.90+38.0% | 123.10-36.8% | 194.80+13.0% | 172.40+19.0% | 144.90-4.2% | 151.20 |
| Net Profit | 179.70+8.3% | 165.90+17.6% | 141.10+53.2% | 92.10-36.8% | 145.70+12.7% | 129.30-12.9% | 148.40+29.6% | 114.50 |
| KEY METRICS | ||||||||
| OPM % | 30.90%-0.30pp | 31.20%+4.32pp | 26.88%+4.16pp | 22.72%-8.03pp | 30.75%+2.13pp | 28.62%+1.06pp | 27.56%+9.00pp | 18.56% |
| NPM % | 20.75%-0.14pp | 20.89%+1.08pp | 19.81%+5.83pp | 13.98%-6.19pp | 20.17%+0.78pp | 19.39%-5.24pp | 24.63%+4.10pp | 20.53% |
| EPS | 10.75+8.1% | 9.94+17.6% | 8.45+53.1% | 5.52-68.4% | 17.46+12.6% | 15.51-12.9% | 17.80+29.5% | 13.74 |
Corporate Events
Board MeetingLALPATHLAB
20264Nov
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingLALPATHLAB
202624Sep
Board Meeting
The Board of Directors considered and approved the acquisiti…
BSE Filing ↗ Board MeetingLALPATHLAB
202624Jul
Board Meeting
The meeting of the Board of Directors is scheduled to be hel…
BSE Filing ↗ Board MeetingLALPATHLAB
202630Apr
Board Meeting
To consider and approve the Audited (Standalone & Consolidat…
BSE Filing ↗ Board MeetingLALPATHLAB
202630Jan
Board Meeting
Update on board meeting, Consider and approve the Un-audited…
BSE Filing ↗ Board MeetingLALPATHLAB
202423Oct
Board Meeting
Approval Of The Un-Audited (Standalone & Consolidated) Finan…
BSE Filing ↗ Board MeetingLALPATHLAB
202410May
Board Meeting
Consider and approve Audited (Standalone & Consolidated) Fin…
BSE Filing ↗ Board MeetingLALPATHLAB
20241Feb
Board Meeting
Consideration and approval of Un-audited Financial Results f…
BSE Filing ↗ Board MeetingLALPATHLAB
20232Nov
Board Meeting
consider and approve unaudited financial results for the Qua…
BSE Filing ↗